The silicone coating that helps the needle slide in smoothly wears off, causing more friction and potential damage to your skin
By encouraging the release of insulin, GLP-1 agonists can help individuals with T2DM better manage their blood glucose levels and avoid complications associated with the disease, such as chronic inflammation, nerve damage, and diseases affecting the kidneys, eyes, and cardiovascular system
Start your intake Regulatory Changes and the End of the Shortage On February 21, 2025, the FDA officially announced that the shortage of semaglutide had ended
Allergy-wise, there is very low risk for this ingredient
For complete information about DSIP therapy, potential side effects, and contraindications, please schedule a consultation with our medical team